Emmaus Life Sciences, Inc. (EMMA)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 29.59 Million | 18.39 Million | 20.61 Million | 23.16 Million | 22.75 Million | 1.31 Million |
| Cost of Revenue | 1.34 Million | 2.58 Million | 3.31 Million | 2.24 Million | 1.09 Million | 827.4 Thousand |
| Gross Profit | 28.25 Million | 15.8 Million | 17.29 Million | 20.91 Million | 21.65 Million | 488.1 Thousand |
| Operating Expenses | 24.71 Million | 22.38 Million | 23.42 Million | 20.95 Million | 26.17 Million | 10.73 Million |
| Selling, General and Administrative Expenses | 23.52 Million | 20.66 Million | 19.31 Million | 18.54 Million | 23.98 Million | 9.35 Million |
| Research and Development Expenses | 1.18 Million | 1.72 Million | 4.11 Million | 2.4 Million | 2.18 Million | 1.37 Million |
| Other Expenses | - | -3.97 Million | - | - | -3.34 Million | - |
| Cost and Expenses | 26.05 Million | 24.97 Million | 26.73 Million | 23.19 Million | 27.26 Million | 11.56 Million |
| Operating Income | 3.54 Million | -6.58 Million | -6.12 Million | -43 Thousand | -4.51 Million | -10.24 Million |
| Interest Expense | 7.38 Million | 5.01 Million | 3.1 Million | 5.98 Million | 27.39 Million | 86.3 Thousand |
| Income Tax Expense | -59 Thousand | 60 Thousand | 25 Thousand | -381 Thousand | 164 Thousand | 1900.00 |
| Earnings before Tax | -3.79 Million | -10.62 Million | -15.92 Million | 719 Thousand | -54.67 Million | -10.33 Million |
| Net Income | -3.73 Million | -10.68 Million | -15.94 Million | 1.35 Million | -54.84 Million | -9.59 Million |
| Earnings Per Share Basic | -0.07 | -0.22 | -0.32 | 0.03 | -1.30 | -11.08 |
| Earnings Per Share Diluted | -0.07 | -0.22 | -0.32 | 0.03 | -1.30 | -11.08 |
| Weighted Average Shares Outstanding | 53.1 Million | 49.43 Million | 49.25 Million | 48.89 Million | 42.25 Million | 866.59 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 53.1 Million | 49.43 Million | 49.25 Million | 48.89 Million | 42.25 Million | 866.59 Thousand |
| Gross Margin | 0.95 | 0.86 | 0.84 | 0.90 | 0.95 | 0.37 |
| EBIT Margin | 0.12 | -0.36 | -0.39 | 0.00 | -0.36 | -7.70 |
| Profit Margin | -0.13 | -0.58 | -0.77 | 0.06 | -2.41 | -7.30 |
| EBITDA | 3.57 Million | -5.49 Million | -12.76 Million | 28 Thousand | -26.98 Million | -10.13 Million |
| Earnings Before Tax Margin | 0.12 | -0.36 | -0.30 | -0.00 | -0.20 | -7.79 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.37 Million | 2.5 Million | 29.59 Million | 7.06 Million | 5.01 Million | 10.75 Million |
| Cost of Revenue | 241 Thousand | 257 Thousand | 1.37 Million | 191 Thousand | 214 Thousand | 508 Thousand |
| Gross Profit | 5.13 Million | 2.24 Million | 28.22 Million | 6.87 Million | 4.8 Million | 10.25 Million |
| Operating Expenses | 4.55 Million | 4.98 Million | 24.68 Million | 5.52 Million | 4.78 Million | 6.92 Million |
| Selling, General and Administrative Expenses | 4.36 Million | 4.8 Million | - | 5.35 Million | 4.36 Million | 6.6 Million |
| Research and Development Expenses | 191 Thousand | 183 Thousand | - | 166 Thousand | 414 Thousand | 320 Thousand |
| Other Expenses | - | - | - | 429 Thousand | - | - |
| Cost and Expenses | 4.79 Million | 5.24 Million | 26.05 Million | 5.71 Million | 4.99 Million | 7.43 Million |
| Operating Income | 582 Thousand | -2.74 Million | 3.54 Million | 1.35 Million | 24 Thousand | 3.32 Million |
| Interest Expense | 966 Thousand | 1.91 Million | 7.38 Million | 2.17 Million | 1.9 Million | 1.79 Million |
| Income Tax Expense | 31 Thousand | -7000.00 | -59 Thousand | -112 Thousand | 38 Thousand | -34 Thousand |
| Earnings before Tax | -2.15 Million | -4.35 Million | -3.79 Million | 1.09 Million | 105 Thousand | -1.51 Million |
| Net Income | -2.18 Million | -4.34 Million | -3.73 Million | 1.2 Million | 67 Thousand | -1.48 Million |
| Earnings Per Share Basic | -0.03 | -0.07 | - | 0.02 | 0.00 | -0.03 |
| Earnings Per Share Diluted | -0.03 | -0.07 | - | 0.02 | 0.00 | -0.03 |
| Weighted Average Shares Outstanding | 63.35 Million | 61.84 Million | 53.1 Million | 61.84 Million | 53.63 Million | 52.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 63.35 Million | 61.84 Million | 53.1 Million | 61.84 Million | 138.37 Million | 52.86 Million |
| Gross Margin | 0.96 | 0.90 | 0.95 | 0.97 | 0.96 | 0.95 |
| EBIT Margin | 0.13 | -1.03 | - | 0.19 | -0.03 | 0.29 |
| Profit Margin | -0.41 | -1.74 | -0.13 | 0.17 | 0.01 | -0.14 |
| EBITDA | 723 Thousand | -2.58 Million | - | 1.36 Million | -168 Thousand | 3.06 Million |
| Earnings Before Tax Margin | 0.11 | -1.09 | 0.12 | 0.19 | 0.00 | 0.31 |
004150
2210
MDALF
KLBN4
H30
1981